Shares of Cardiol Therapeutics Inc. (TSE:CRDL – Get Free Report) shot up 1.8% during mid-day trading on Thursday . The company traded as high as C$2.23 and last traded at C$2.22. 181,842 shares traded hands during trading, an increase of 31% from the average session volume of 138,904 shares. The stock had previously closed at C$2.18.
Cardiol Therapeutics Price Performance
The stock has a market cap of C$155.13 million, a price-to-earnings ratio of -5.05 and a beta of 0.70. The company has a 50 day simple moving average of C$2.69 and a 200-day simple moving average of C$2.85. The company has a current ratio of 2.39, a quick ratio of 6.84 and a debt-to-equity ratio of 1.07.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.
Further Reading
- Five stocks we like better than Cardiol Therapeutics
- How to Calculate Options Profits
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Dividend Payout Ratio Calculator
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
